Soluble Fms-like tyrosine cinase 1 (sFLt-1) and antibody against AT1-receptor in preclempsia a comparison in a blind study design

Documenti analoghi

• Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.
  di: Verlohren, S, et al.
  Pubblicazione: (2008)
• Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
  di: Herse, F, et al.
  Pubblicazione: (2009)
• Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
  di: Laura Ehrlich, et al.
  Pubblicazione: (2017-04-01)
• Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
  di: Natalie J. Hannan, et al.
  Pubblicazione: (2017-05-01)
• Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia
  di: John Wantania, et al.
  Pubblicazione: (2013-08-01)